Charles A Rowland Jr Viking Therapeutics, Inc. (VKTX) insider trading activity

Charles A Rowland Jr is Director of Viking Therapeutics, Inc.. Currently has a direct ownership of 30,000 shares of VKTX, which is worth approximately $2.15 Million. The most recent transaction as insider was on May 16, 2023, when has been sold 40,000 shares (Common stock, par value $0.00001 per share) at a price of $25.0 per share, resulting in proceeds of $1,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30K

0% 3M change

0% 12M change

Total Value Held $2.15 Million

Charles A Rowland Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 16 2023	SELL Open market or private sale	$1,000,000 $25.0 p/Share	40,000 Reduced 57.14%	30,000 Common stock, par valu...
May 16 2023	BUY Exercise of conversion of derivative security	$43,200 $1.08 p/Share	40,000 Added 36.36%	70,000 Common stock, par valu...

Also insider at

BPMC

Blueprint Medicines Corp Healthcare

Director

GBIO

Generation Bio Co. Healthcare

ORTX

Orchard Therapeutics plc Healthcare

NBRV

Nabriva Therapeutics plc Healthcare

Director

CAR